BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32809048)

  • 1. Anti-inflammatory capacity of Apremilast in human chondrocytes is dependent on SOX-9.
    Zhang Y; Huang X; Yuan Y
    Inflamm Res; 2020 Nov; 69(11):1123-1132. PubMed ID: 32809048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX9 is a regulator of ADAMTSs-induced cartilage degeneration at the early stage of human osteoarthritis.
    Zhang Q; Ji Q; Wang X; Kang L; Fu Y; Yin Y; Li Z; Liu Y; Xu X; Wang Y
    Osteoarthritis Cartilage; 2015 Dec; 23(12):2259-2268. PubMed ID: 26162802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linagliptin ameliorated interleukin-29-induced reduction of extracellular matrix genes through the nuclear factor erythroid 2-related factor 2 (Nrf2)/sry-type high-mobility-group box (SOX)-9 axis in an
    Li Y; Zhan P; Wang Q; Zhang M; Huang S; Chen D
    Bioengineered; 2022 Feb; 13(2):3775-3784. PubMed ID: 35081865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrilin-3 induction of IL-1 receptor antagonist is required for up-regulating collagen II and aggrecan and down-regulating ADAMTS-5 gene expression.
    Jayasuriya CT; Goldring MB; Terek R; Chen Q
    Arthritis Res Ther; 2012 Sep; 14(5):R197. PubMed ID: 22967398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etomidate ameliorated advanced glycation end-products (AGEs)-induced reduction of extracellular matrix genes expression in chondrocytes.
    Sun X; Zhang J; Li Y; Ren W; Wang L
    Bioengineered; 2021 Dec; 12(1):4191-4200. PubMed ID: 34308765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes.
    Roman-Blas JA; Stokes DG; Jimenez SA
    Osteoarthritis Cartilage; 2007 Dec; 15(12):1367-77. PubMed ID: 17604656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-29a and MiR-140 Protect Chondrocytes against the Anti-Proliferation and Cell Matrix Signaling Changes by IL-1β.
    Li X; Zhen Z; Tang G; Zheng C; Yang G
    Mol Cells; 2016 Feb; 39(2):103-10. PubMed ID: 26608362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of Sirt1 by tyrosol suppresses apoptosis and inflammation and modulates extracellular matrix remodeling in interleukin-1β-stimulated human nucleus pulposus cells through activation of PI3K/Akt pathway.
    Qi W; Ren D; Wang P; Song Z; Wu H; Yao S; Geng L; Su Y; Bai X
    Int Immunopharmacol; 2020 Nov; 88():106904. PubMed ID: 32866785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone 1-34 reduces dexamethasone-induced terminal differentiation in human articular chondrocytes.
    Chang LH; Wu SC; Chen CH; Wang GJ; Chang JK; Ho ML
    Toxicology; 2016 Aug; 368-369():116-128. PubMed ID: 27608943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of MiR-138-5p Protects Chondrocytes ATDC5 and CHON-001 from IL-1 β-induced Inflammation
    Chunlei H; Chang Z; Sheng L; Yanchun Z; Lulin L; Daozhang C
    Curr Pharm Des; 2020; 25(43):4613-4621. PubMed ID: 31486753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vorinostat ameliorates IL-1α-induced reduction of type II collagen by inhibiting the expression of ELF3 in chondrocytes.
    Miao X; Wu Y; Wang P; Zhang Q; Zhou C; Yu X; Cao L
    J Biochem Mol Toxicol; 2021 Sep; 35(9):e22844. PubMed ID: 34250664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trelagliptin ameliorates IL-1β-impaired chondrocyte function via the AMPK/SOX-9 pathway.
    Liu J; Zuo Q; Li Z; Chen J; Liu F
    Mol Immunol; 2021 Dec; 140():70-76. PubMed ID: 34666245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of Sox-9 transcription factor.
    Kolettas E; Muir HI; Barrett JC; Hardingham TE
    Rheumatology (Oxford); 2001 Oct; 40(10):1146-56. PubMed ID: 11600745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonism of GPR120 prevented IL-1β-induced reduction of extracellular matrix through SOX-9.
    Xu Z; Ke T; Zhang Y; Fu C; He W
    Aging (Albany NY); 2020 Jun; 12(12):12074-12085. PubMed ID: 32580167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligustrazine protects chondrocyte against IL-1β induced injury by regulation of SOX9/NF-κB signaling pathway.
    Yu T; Qu J; Wang Y; Jin H
    J Cell Biochem; 2018 Sep; 119(9):7419-7430. PubMed ID: 29806884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical loading stimulates chondrogenesis via the PKA/CREB-Sox9 and PP2A pathways in chicken micromass cultures.
    Juhász T; Matta C; Somogyi C; Katona É; Takács R; Soha RF; Szabó IA; Cserháti C; Sződy R; Karácsonyi Z; Bakó E; Gergely P; Zákány R
    Cell Signal; 2014 Mar; 26(3):468-82. PubMed ID: 24333667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suramin enhances chondrogenic properties by regulating the p67
    Liu ZM; Shen PC; Lu CC; Chou SH; Tien YC
    Bone Joint Res; 2022 Oct; 11(10):723-738. PubMed ID: 36222195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELF3 modulates type II collagen gene (COL2A1) transcription in chondrocytes by inhibiting SOX9-CBP/p300-driven histone acetyltransferase activity.
    Otero M; Peng H; Hachem KE; Culley KL; Wondimu EB; Quinn J; Asahara H; Tsuchimochi K; Hashimoto K; Goldring MB
    Connect Tissue Res; 2017 Jan; 58(1):15-26. PubMed ID: 27310669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Febuxostat mitigates IL-18-induced inflammatory response and reduction of extracellular matrix gene.
    Geng Q; Zhang H; Cui Y; Wei Q; Wang S
    Am J Transl Res; 2021; 13(3):979-987. PubMed ID: 33841634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible factor 1alpha inhibits the fibroblast-like markers type I and type III collagen during hypoxia-induced chondrocyte redifferentiation: hypoxia not only induces type II collagen and aggrecan, but it also inhibits type I and type III collagen in the hypoxia-inducible factor 1alpha-dependent redifferentiation of chondrocytes.
    Duval E; Leclercq S; Elissalde JM; Demoor M; Galéra P; Boumédiene K
    Arthritis Rheum; 2009 Oct; 60(10):3038-48. PubMed ID: 19790048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.